Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131900) titled 'A Study on the Potential Applications of Urinary Proteomic and Peptidomic Analysis in Tumor Diseases' on Sept. 7.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Zhujiang Hospital of Southern Medical University
Condition:
Lung cancer, liver cancer and colorectal cancer
Intervention:
Case Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Case Group:1500;Control Group:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340528
Published by HT Digital ...